Additionally, Kaplan–Meier progression-free survival curves for non-small cell lung cancer patients with malignant pleural effusion showed that high soluble CD40 is associated with poor prognosis (HR = 0.4643, P = 0.045 (Mu et al., 2015). Here, CD40 is linked to non-small cell lung carcinoma.